Company intelligence / Profile preview
Alseres Pharmaceuticals, Inc.
Auburndale, Massachusetts, United Statesalseres.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Alseres Pharmaceuticals' lead product Altropane is in Phase III clinical trials for the diagnosis of Parkinsonian Syndromes including Parkinson's disease. The company received Special Protocol Assessment (SPA) agreement from FDA for the Phase III POET-2 trial of Altropane in 2009.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small molecule drugDiagnostic radiopharmaceuticalsRecombinant protein
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Molecular NeuroImaging, LLC
Beyond the preview
Go deeper on Alseres Pharmaceuticals, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alseres Pharmaceuticals, Inc..